Author Question: The appropriate measure for risk according to the capital asset pricing model is A) the standard ... (Read 34 times)

ishan

  • Hero Member
  • *****
  • Posts: 546
The appropriate measure for risk according to the capital asset pricing model is
 
  A) the standard deviation of a firm's stock returns.
  B) the standard deviation of a firm's cash flows.
  C) alpha.
  D) beta.

Question 2

Given a discount rate of 0, which of the following has the greatest present value? ONE, a series of 10 equal annual end-of-the cash flows of 100 each, TWO, just like ONE except the first 5 cash flows are only 50 but the last 5 cash flows are 150
 
  , or THREE, just like ONE except the 10 100 cash flows are at the beginning of the period.
  A) ONE
  B) TWO
  C) THREE
  D) The choices all have equal present values.


kxciann

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

D

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library